Response adaptive designs for clinical trials with continuous outcomes
Response adaptive designs are developed for ethical considerations, which sequentially modify the treatment allocations based on the accumulating information in the trial so more patients receive the potentially better treatment. Yi and Wang (2009) proposed a variance-penalized criterion to evaluate...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
2013
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/1993/14424 |